Did Moderna Just Jump Ahead of Rivals in a Potential Billion-Dollar Market?The Motley Fool • 10/06/23
Moderna (MRNA) to Advance COVID/Flu Combo Jab to Late-Stage StudyZacks Investment Research • 10/05/23
Moderna Files for Health Canada Review of its Respiratory Syncytial Virus (RSV) Vaccine, mRNA-1345Accesswire • 10/05/23
Moderna Announces Positive Phase 1/2 Data from mRNA-1083, the Company's Combination Vaccine Against Influenza and COVID-19Accesswire • 10/04/23
Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID VaccineThe Motley Fool • 09/30/23
Moderna Recommends Shareholders Reject Amended “Mini-Tender” Offer by TRC Capital Investment CorporationAccesswire • 09/29/23
Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.Market Watch • 09/26/23
Analysts Predict A 19% Surge For The S&P 500 Soon — Lifted By 10 StocksInvestors Business Daily • 09/25/23